NOTICE
ANSM - Updated on : 21/05/2021
Product name
STORINYL, syrup
Sidebar
Please read this leaflet carefully before taking this medicine, as it contains important information for you.
Always take this medicine exactly as it is prescribed by your doctor or pharmacist.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist for any advice or information you may need.
- If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if you do not feel any improvement or if you feel less well after 3 days.
What does this leaflet contain?
1. What is STORINYL syrup and what is it used for?
2. What do I need to know before taking STORINYL, syrup?
3. How should STORINYL syrup be taken?
4. What are the possible side effects?
5. How should STORINYL syrup be stored?
6. Package contents and other information.
1. WHAT IS STORINYL, syrup AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: homeopathic medicine
STORINYL, syrup is a homeopathic medicine traditionally used in the symptomatic treatment of:
- colds (nasal congestion, runny nose, sneezing, minor sore throat).
- dry and hacking coughs.
2. WHAT DO I HAVE TO KNOW BEFORE TAKING STORINYL, syrup?
Never take STORINYL, syrup:
- If you are allergic to any of the active ingredients or to any of the other ingredients listed in section 6.
Warnings and precautions
- If symptoms persist or worsen beyond 3 days, or if fever exceeds 38.5°C, consult a doctor.
- Patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases) should not take this medicine.
- This medicine contains 4.3 g of sucrose for a 5 ml dose and 13.0 g for a 15 ml dose, to be taken into account for patients with diabetes mellitus.
- This medicine contains 13.2 mg sodium benzoate for a 5 ml dose and 39.6 mg for a 15 ml dose, equivalent to 2.64 mg/ml. Sodium benzoate may increase the risk of dicterus (yellowing of the skin and eyes) in neonates (up to 4 weeks of age).
- This drug contains less than 1 mmol (23 mg) sodium per 5 ml and 15 ml dose, i.e. it is essentially "sodium-free".
Children
Not applicable.
Other medicines and STORINYL, syrup
Tell your doctor or pharmacist if you are taking, have recently taken or may take any other medicines.
STORINYL, syrup with food and drink
Not applicable.
Pregnancy and breast-feeding
STORINYL syrup may be taken during pregnancy and while breast-feeding.
Driving and use of machinery
Not applicable.
STORINYL, syrup contains sucrose and sodium benzoate (E211).
If your doctor has informed you that you are intolerant to certain sugars, contact your doctor before taking this medicine.
3. HOW DO I TAKE STORINYL, syrup?
Dosage
This medicine should not be used in children under 2 years of age without medical advice.
Adults and children over 12 : 1 dose of 15 ml from a measuring cup 3 to 5 times a day.
Children aged 2 to 12: 1 dose of 5 ml from the measuring cup 3 times a day.
Children under 2 years: 1 dose of 5 ml from the measuring cup, diluted in a small amount of liquid, 3 times a day.
Take at intervals as soon as symptoms improve, and discontinue as soon as symptoms disappear.
Duration of treatment
Treatment duration should not exceed one week.
Method of administration
Oral administration
If you have taken more STORINYL syrup than you should have :
Consult your doctor or pharmacist immediately.
If you forget to take STORINYL, syrup:
Do not take a double dose to make up for the one you forgot to take.
If you stop taking STORINYL, syrup:
Not applicable.
If you have any further questions about the use of this medicine, please ask your doctor or pharmacist.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, this product may cause undesirable effects, but they do not occur systematically in everyone.
Reporting side effects
If you experience any side effects, please tell your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Centres Régionaux de Pharmacovigilance - Website: www.signalement-sante.gouv.fr
By reporting adverse reactions, you are helping to provide more information on drug safety.
5. HOW SHOULD I USE STORINYL, syrup?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the packaging. The expiration date refers to the last day of that month.
Do not keep beyond 6 months after first opening.
Do not dispose of any medicine down the drain or in the household waste. Ask your pharmacist to identify any medicines you no longer use. These measures will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What STORINYL syrup contains
- The active ingredients are :
Dulcamara 5 CH..................................................................................................................... 0.01 g
Ferrum phosphoricum 9 CH.................................................................................................... 0.01 g
Hydrastis canadensis 9 CH..................................................................................................... 0.01 g
Kalium bichromicum 9 CH....................................................................................................... 0.01 g
Nux vomica 9 CH................................................................................................................... 0.01 g
Per 100 g syrup
- The other components are :
Purified water, sucrose, sodium benzoate (E211), citric acid monohydrate (E330).
What STORINYL syrup is and what it contains
This medicine is available as a syrup.
One box contains a 200 mLbottle and a measuring cup (15 mL) graduated at 5 mL and 15 mL.
Marketing authorization holder
BOIRON
2 AVENUE DE LOUEST LYONNAIS
69510 MESSIMY
FRANCE
Marketing authorization holder
BOIRON
2 AVENUE DE LOUEST LYONNAIS
69510 MESSIMY
FRANCE
Manufacturer
BOIRON
2 AVENUE DE LOUEST LYONNAIS
69510 MESSIMY
FRANCE
Product names in member states of the European Economic Area
Not applicable.
The last date on which this leaflet was revised was :
[to be completed subsequently by the holder].
Other
Detailed information on this drug is available on the ANSM (France) website.